Impact of antibiotic therapy in severe community-acquired pneumonia: Data from the Infauci study

Combination AT with a macrolide may be the most suitable AT strategy to improve both short and long term outcome of severe CAP patients. AT > 7 days had no survival benefit and was associated with a longer LOS.